Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MEROPENEM TRIHYDRATE
Milpharm Limited
J01DH02
MEROPENEM TRIHYDRATE
1 Grams
Pdr for Soln Inj/Inf
Product subject to prescription which may not be renewed (A)
Carbapenems
Transfer Pending
2016-03-11
PACKAGE LEAFLET: INFORMATION FOR THE USER MEROPENEM MILPHARM 500 MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION MEROPENEM MILPHARM 1 G POWDER FOR SOLUTION FOR INJECTION OR INFUSION meropenem READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or nurse.This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Meropenem Milpharm is and what it is used for 2. What you need to know before you take Meropenem Milpharm 3. How to take Meropenem Milpharm 4. Possible side effects 5. How to store Meropenem Milpharm 6. Contents of the pack and other information 1. WHAT MEROPENEM MILPHARM IS AND WHAT IT IS USED FOR Meropenem belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria, which can cause serious infections. Infection affecting the lungs (pneumonia). Lung and bronchial infections in patients suffering from cystic fibrosis. Complicated urinary tract infections. Complicated infections in the abdomen. Infections that you can catch during or after the delivery. Complicated skin and soft tissues infections. Acute bacterial infection of the brain (meningitis). Meropenem Milpharm may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Meropenem Milpharm may be us Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Meropenem Milpharm 1g Powder for solution for injection or infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Meropenem Milpharm 1 g:_ Each vial of powder for solution for injection or infusion contains 1141.56 mg meropenem trihydrate equivalent to 1 g anhydrous meropenem. Excipients with known effect: Each vial contains 208 mg sodium carbonate approximately 4.0 mmol of sodium (approximately 90 mg). Each ml of reconstituted solution contains 50 mg Meropenem. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection or infusion. A White to pale yellow crystalline powder. pH of the product after reconstitution is 7.3 to 8.3 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Meropenem Milpharm is indicated for the treatment of the following infections in adults and children over 3 months of age (see sections 4.4 and 5.1): • Severe pneumonia, including hospital and ventilator-associated pneumonia. • Broncho-pulmonary infections in cystic fibrosis • Complicated urinary tract infections • Complicated intra-abdominal infections • Intra- and post-partum infections • Complicated skin and soft tissue infections • Acute bacterial meningitis Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Meropenem Milpharm may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The tables below provide general recommendations for dosing. The dose of meropenem administered and the durat Read the complete document